Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Christopher J Ryerson

Showing results (101-110 of 329) with videos related to

Pageof 33
Sort By:
Expert Review of Respiratory Medicine|January 30, 2020
Acute exacerbations of idiopathic pulmonary fibrosis (AE-IPF): an overview of current and future therapeutic strategiesDavide Biondini, Elisabetta Balestro, Nicola Sverzellati, et al.
Chest|December 18, 2021
Malignancy Risk Associated With Mycophenolate Mofetil or Azathioprine in Patients With Fibrotic Interstitial Lung DiseaseStacey D Lok, Alyson W Wong, Yet H Khor, et al.
Chest|June 8, 2021
Pulmonary Apical Cap as a Potential Risk Factor for Pleuroparenchymal FibroelastosisDaniel-Costin Marinescu, John English, Tony Sedlic, et al.
The European Respiratory Journal|March 19, 2026
Associations between High-Density Lipoprotein Cholesterol and Interstitial Lung Abnormalities in the Korean National Lung Cancer ScreeningHyungjin Kim, Eunseo Jo, Jinseob Kim, et al.
Respiratory Research|March 15, 2019
Body composition, muscle function, and physical performance in fibrotic interstitial lung disease: a prospective cohort studySabina A Guler, Seo Am Hur, Scott A Lear, et al.
JMIR Public Health and Surveillance|May 31, 2021
Social Media Content of Idiopathic Pulmonary Fibrosis Groups and Pages on Facebook: Cross-sectional AnalysisAndrew Kochan, Shaun Ong, Sabina Guler, et al.
ERJ Open Research|May 3, 2019
Effects of nintedanib in patients with idiopathic pulmonary fibrosis by GAP stageChristopher J Ryerson, Martin Kolb, Luca Richeldi, et al.
American Journal of Respiratory and Critical Care Medicine|April 9, 2021
Update in Interstitial Lung Disease 2020Anna J Podolanczuk, Alyson W Wong, Shigeki Saito, et al.
The European Respiratory Journal|June 18, 2021
A contemporary practical approach to the multidisciplinary management of unclassifiable interstitial lung diseaseChristopher J Ryerson, Tamera J Corte, Jeffrey L Myers, et al.
American Journal of Respiratory and Critical Care Medicine|February 25, 2026
Bronchiolocentric interstitial pneumonia is a more accurate ILD classification than hypersensitivity pneumonitis: ProChristopher J Ryerson, Ayodeji Adegunsoye, Lida P Hariri, et al.
Pageof 33

Showing results (101-110 of 329) with videos related to

Sort By:
Pageof 33
Expert Review of Respiratory Medicine|January 30, 2020
Acute exacerbations of idiopathic pulmonary fibrosis (AE-IPF): an overview of current and future therapeutic strategiesDavide Biondini, Elisabetta Balestro, Nicola Sverzellati, et al.
Chest|December 18, 2021
Malignancy Risk Associated With Mycophenolate Mofetil or Azathioprine in Patients With Fibrotic Interstitial Lung DiseaseStacey D Lok, Alyson W Wong, Yet H Khor, et al.
Chest|June 8, 2021
Pulmonary Apical Cap as a Potential Risk Factor for Pleuroparenchymal FibroelastosisDaniel-Costin Marinescu, John English, Tony Sedlic, et al.
The European Respiratory Journal|March 19, 2026
Associations between High-Density Lipoprotein Cholesterol and Interstitial Lung Abnormalities in the Korean National Lung Cancer ScreeningHyungjin Kim, Eunseo Jo, Jinseob Kim, et al.
Respiratory Research|March 15, 2019
Body composition, muscle function, and physical performance in fibrotic interstitial lung disease: a prospective cohort studySabina A Guler, Seo Am Hur, Scott A Lear, et al.
JMIR Public Health and Surveillance|May 31, 2021
Social Media Content of Idiopathic Pulmonary Fibrosis Groups and Pages on Facebook: Cross-sectional AnalysisAndrew Kochan, Shaun Ong, Sabina Guler, et al.
ERJ Open Research|May 3, 2019
Effects of nintedanib in patients with idiopathic pulmonary fibrosis by GAP stageChristopher J Ryerson, Martin Kolb, Luca Richeldi, et al.
American Journal of Respiratory and Critical Care Medicine|April 9, 2021
Update in Interstitial Lung Disease 2020Anna J Podolanczuk, Alyson W Wong, Shigeki Saito, et al.
The European Respiratory Journal|June 18, 2021
A contemporary practical approach to the multidisciplinary management of unclassifiable interstitial lung diseaseChristopher J Ryerson, Tamera J Corte, Jeffrey L Myers, et al.
American Journal of Respiratory and Critical Care Medicine|February 25, 2026
Bronchiolocentric interstitial pneumonia is a more accurate ILD classification than hypersensitivity pneumonitis: ProChristopher J Ryerson, Ayodeji Adegunsoye, Lida P Hariri, et al.
Pageof 33